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Abstract
Annulated benzothiazoloquinazolines have been synthesized by a diversity oriented simple and convenient
synthesis involving one-pot three-component reaction of substituted 2-aminobenzothiazoles with a-tetralone and
aromatic/heteroaromatic aldehydes in ethanol in the presence of catalytic amount of triethylamine. The
synthesized compounds have been characterized by their elemental analyses and spectral data.
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Background
The synthesis of fused heterocycles has attracted consid-
erable interest in heterocyclic chemistry as the fusion of
biodynamic heterosystems has proved to be a very
attractive and useful for the design of new molecular
framework of potential drugs with varying pharmacolo-
gical activities. A major challenge of modern drug dis-
covery is to design highly efficient chemical reaction
sequences which provide molecules containing maxi-
mum complexity and structural diversity with interest-
ing bioactivities in minimum number of synthetic steps.
Recently, multicomponent reactions have attracted
attention of chemical and pharmaceutical research and
emerged as highly efficient and synthetically useful reac-
tions for the preparation of structurally diverse drug-
like heterocyclic compounds.
There has been an increasing interest in the chemistry
of quinazolines [1-5] because of being present quinazo-
line heterocyclic system as a building block in many nat-
ural and synthetic products capable of exhibiting a wide
variety of biological and pharmacological activities [6].
Quinazolines have been reported to exhibit anti-inflam-
matory [7], antihypertensive [8], anticancer [9], antitu-
mor [10] and antibacterial [11] activities. Quinazoline
and its derivatives have recently been evaluated as
antagonist of various biological receptors such as 5-
HT5A [12] related disease calcitonin gene - related
peptide [13] and vasopressin V3 receptors [14]. Ben-
zothiazole has also been an interesting heterocyclic sys-
tem in drug research on account of significant biological
activities of its fused derivatives [15-17]. Thiazoloquina-
zolines, have shown significant activity against cancer
[18]. Thiazoloquinazolines have also been identified as
cyclin dependent kinase (CDK) and glycogen synthase
kinase (GSK-3) inhibitors [19,20].
Result and discussion
The syntheses of heterocycles with fused heterosystems
involve, in most of the cases, multistep synthetic meth-
ods which require a large number of synthetic opera-
tions including extraction and purification of each
individual step. The multistep synthetic methodologies,
therefore, led to the synthetic inefficiency with the gen-
eration of large amounts of waste. The methods
reported in the literature [21,22] for the synthesis of
thiazoloquinazolines irrespective of positions of attach-
ment of both the heterocyclic systems involved multi-
steps in which the formation of thiazole ring before the
quinazoline ring induced low subsequent reactivity.
Thiazoloquinazolines prepared by reaction of 2-amino-
benzylamine with aromatic amine and then with 2-mer-
captopropionic acid also involved multistep reaction.
However, after detailed literature survey it was observed
that there were only limited publications devoted to the
synthesis of especially benzothiazoloquinazolines which
involved cyclocondensation of 2-aminobenzothiazoles * Correspondence: mahendrakpathak@gmail.com
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provided the original work is properly cited.with Mannich bases obtained in the first step as a result
of Mannich reaction [23]. The multistep synthesis of
benzothiazoloquinazolines suffered from some flaws
including low yields, side products and tedious workup.
In continuation of our research programme on the
synthesis of nitrogen and sulphur containing novel het-
erocycles [24-31] of pharmaceutical interest and in view
of the operational simplicity and intrinsic convergence
(atom economy) of multicomponent reactions [32-36] in
addition to their potential to introduce considerable
structural diversity, we have synthesized annulated ben-
zothiazoloquinazolines incorporating three biodynamic
privileged heterosystems by a simple and convenient
method involving multicomponent reaction of substi-
tuted 2-aminobenzothiazoles with a-tetralone and aro-
matic/heteroaromatic aldehydes in ethanol in the
presence of catalytic amount of triethylamine, wherein
2-aminobenzothiazoles with both endocyclic nitrogen
and exocyclic amino group participate as 1,3-binucleo-
phile synthones in the formation of annulated ben-
zothiazoloquinazolines (Scheme 1).
The reaction is believed to proceed to involve Knoeve-
nagal condensation between a-tetralone and aromatic/
heteroaromatic aldehyde in the initial step to form a,b-
unsaturated ketone which undergoes Michael type addi-
tion with the nucleophilic endocyclic nitrogen of 2-ami-
nobenzothiazole under the reaction conditions. The
adduct formed is then cyclised intramolecularly with the
lose of water molecule to provide annulated benzothia-
zolo[2,3-b] quinazolines. These reactions have taken
place in one-flask domino manner and the enone system
generated in situ immediately undergoes Michael type
addition with 2-aminobenzothiazoles and subsequent
cyclization. The possibility of formation of isomeric pro-
duct involving nucleophilic attack of exocyclic amino
group has been completely discarded on the basis of
spectral characteristics. Annulated benzothiazoloquina-
zolines have also been synthesized by a multistep synth-
esis involving the reaction of substituted 2-
aminobenzothiazoles with chalcones obtained by the
reaction of a-tetralone with thiophene-2-carbaldehyde/
p-methoxybenzaldehyde in the presence of catalytic
amount of triethylamine. It has been observed that with
the use of chalcones the reaction occurs in two steps
relatively in longer time (6-8 h) with the moderate yields
(50-60%) of annulated benzothiazoloquinazolines. But
when the chalcones are replaced by their synthetic pre-
cursors, a-tetralone and thiophene-2-carbaldehyde/p-
methoxybenzaldehyde, annulated benzothiazoloquinazo-
lines are obtained with excellent yields (75-85%). The
synthesized annulated benzothiazoloquinazolines are
presented in table 1.
The structures of the synthesized compounds were
confirmed by their elemental analyses and spectral data.
Infrared spectra of all the synthesized compounds exhi-
bit an intense unsaturation absorption band in the
region 1605-1610 cm
-1 (C = C). The absorption band in
the region 1620-1654 cm
-1 in the IR spectra of all the
compounds indicated the presence of C = N bond. Two
absorption bands corresponding to asymmetric and
symmetric stretching vibrations of -NH2 group, which
were present in the IR spectra of 2-aminobenzothiazoles,
are absent in the IR spectra of the synthesized com-
pounds.
1H NMR spectra of the synthesized compounds
showed a multiplet in the region δ 7.01-8.08 ppm due
to aromatic protons. The singlet appeared in the region
δ 5.90-6.80 was assigned to the aliphatic proton (C7-H).
The singlet observed in the region δ 3.69-3.84 ppm was
attributed to the methoxy protons, whereas the methyl
protons resonate as a singlet in the region δ 2.34-2.36
ppm in the
1H NMR spectra of annulated benzothiazo-
loquinazolines containing -OCH3 and -CH3 groups
respectively. The multiplets observed in the region δ
2.74-3.23 ppm were assigned to the methylene protons
at C-5 and C-6. In the
13C NMR spectra of the synthe-
sized annulated benzothiazoloquinazolines, the δ values
of most of the carbon atoms of CH3,C H 2,C H ,C=C ,
C = N, C-N, C-O, C-S, C-F and aromatic system could
be determined by distinct resonance signals and were
found to be in agreement with the proposed structures.
Conclusion
In conclusion, we have developed a simple and conveni-
ent diversity oriented one-pot three-component sequen-
tial synthesis for the synthesis of structurally diverse
heterocycles, annulated benzothiazoloquinazolines,
incorporating medicinally privileged heterosystems.
The present method with its mild reaction condi-
tions and operational simplicity enables the sequential
combination of three reactive components; a-tetralone,
thiophene-2-carbaldehyde/p-methoxybenzaldehyde and
2-aminobenzothiazole in one-pot and efficiently incor-
porates structural diversity simply by varying the sub-
stituents or by slight structural modification in the
components involved in the reaction. This new method
has the advantages of higher yields, mild reaction con-
ditions, shorter reaction time, and convenient proce-
dure and can be extended to prepare a library of
structurally diverse drug like small heterocyclic
molecules.
Scheme 1
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Page 2 of 6Table 1 Reaction of 2-aminobenzothiazoles with α-tetralone and aromatic/heteroaromatic aldehydes.
2-aminobenzothiazole a-tetralone Aldehydes product m.p.°C % yield
210-212 76
220-222 80
205-207 77
190-192 75
215-217 80
227-229 80
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Melting points were determined on an electric melting
point apparatus and are uncorrected. The purity of all the
compounds was checked by thin layer chromatography
using various non-aqueous solvents. IR spectra (KBr pellets)
were recorded on Shimadzu-8400S FT-IR Spectrophot-
ometer. The
1H NMR and
13C NMR spectra were scanned
on Jeol AL 300 FT NMR in CDCl3 using TMS as an inter-
nal standard. The chemical shifts are expressed as δ ppm.
Methods
Procedure for the preparation of 7-thien-2-yl/4’-
methoxyphenyl-5, 6-dihydro-7H-benzo [h] benzothiazolo
[2, 3-b] quinazolines
To a magnetically stirred solution of thiophene-2-carbal-
dehyde/p-methoxy benzaldehyde (0.01 mole) and a-tet-
ralone (0.01 mole) in ethanol (20 ml), a catalytic
amount of (C2H5)3N was added slowly and further stir-
red for 30 min. Then 2-aminobenzothiazole (0.01 mole)
was added to the reaction mixture with stirring for 2 h
and then refluxed for 60-90 min in a round bottom
flask fitted with reflux condenser. The progress of the
reaction was monitored by TLC. The precipitate formed
after the completion of reaction was isolated by filtra-
tion. The solid separated out was washed well with etha-
nol, dried and finally crystallized from ethanol.
11-Methyl-7-(thien-2-yl)-5,6-dihydro-7H-benzo[h]
benzothiazolo[2, 3-b]quinazoline (4a)
(4a). m.p. 210-212°C; yield: 76%; IR (KBr, cm
-1): 3100, 2980,
1620, 1605;
1H NMR (300 MHz, CDCl3) δppm: 7.10-7.68
(m, 10H, Ar-H), 5.86 (s, 1H, C7), 3.18-3.23 (m, 2H, CH2),
2.93-3.05 (m, 2H, CH2), 2.36 (s, 3H, CH3);
13C NMR (75
MHz, CDCl3) δppm: 18.38, 26.98, 28.10, 58.32, 119.43,
122.13, 125.34, 125.53, 126.23,126.56, 126.85, 127.80,
127.32, 127.54, 128.26, 130.20, 132.14, 133.65, 134.12,
137.34, 139.14,143.15, 167.35; Anal. Calcd. for C23H18N2S2:
C, 71.47; H, 4.69; N, 7.25; Found: C, 73.65; H, 4.99; N, 7.19.
11-Methoxy-7-(thien-2-yl)-5,6-dihydro-7H-benzo[h]
benzothiazolo [2, 3-b] quinazoline (4b)
(4b) m.p. 220-222°C; yield: 80%, IR (KBr, cm
-1): 3010-
3080, 2975, 1620, 1615;
1H NMR (300 MHz, CDCl3)
δppm: 7.09-7.84 (m, 10H, Ar-H), 5.98 (s, 1H,C7-H), δ
3.84 (s, 3H, OCH3), 2.96-3.22 (m, 4H, CH2,C 5,a n dC 6);
13CN M R( 7 5M H z ,C D C l 3) δppm: 26.9, 28.06, 54.60,
57.20, 115.70, 122.52, 125.29, 125.62, 126.14, 126.45,
127.58, 127.69, 128.08, 129.44, 130.68, 133.12, 133.28,
134.60, 137.20, 139.04, 142.98, 155.61, 167.19 Anal.
Calcd. for C23H18N2OS2: C, 68.63; H, 4.51; N, 6.96;
Found: C, 70.65; H, 4.35; N, 6.99.
9,10-Dichloro-7-(thien-2-yl)-5,6-dihydro-7H-benzo[h]
benzothiazolo-[2, 3-b]quinazoline (4c)
(4c) m.p. 205-207°C; yield: 77%, IR (KBr, cm
-1): 3060,
2972, 1622, 1615;
1HN M R( 3 0 0M H z ,C D C l 3) δppm:
7.08-7.45 (m, 9H, Ar-H), 5.96 (s, 1H,C7-H), δ 3.12-3.24
(m, 2H,CH2) 2.94-2.96 (m, 2H,CH2);
13CN M R( 7 5
MHz, CDCl3) δppm: 26.96, 28.16, 57.23, 119.92, 120.32,
123.46, 125.13, 125.24, 126.23, 126.52, 127.26, 127.46,
128.13, 130.32, 131.82, 133.65, 134.91, 138.03, 139.45,
143.98, 167.16; Anal. Calcd. for C22H14Cl2N2S2:C ,
59.86; H, 3.20; N, 6.35; Found: C, 62.09; H, 3.10; N, 6.45.
11-Fluoro-7-(thien-2-yl)-5,6-dihydro-7H-benzo[h]
benzothiazolo-[2, 3-b]quinazoline (4d)
(4d) m.p. 190-192°C; yield: 75%, IR (KBr, cm
-1): 3075,
2978, 1620, 1610;
1H NMR (300 MHz, CDCl3) δ ppm:
Table 1 Reaction of 2-aminobenzothiazoles with α-tetralone and aromatic/heteroaromatic aldehydes. (Continued)
192-194 74
189-191 75
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Page 4 of 66.92-7.40 (m, 10H, Ar-H), 5.95 (s, 1H, C7-H), δ 3.18-
3.23 (m, 2H,CH2) 3.01-3.05 (m, 2H, CH2);
13C NMR (75
MHz, CDCl3) δppm: 26.78, 28.13, 58.62, 119.23, 120.35,
122.16, 125.28, 125.69, 126.31, 126.65, 127.58, 127.67,
128.23, 131.98, 133.54, 134.46, 138.42, 139.68, 142.06,
153.72, 170.43; Anal. Calcd. for C22H15FN2S2:C ,6 7 . 6 7 ;
H, 3.87; N, 7.17; Found: C, 67.65; H, 3.83; N, 7.13.
11-Methyl-7-(4-methoxyphenyl)-5,6-dihydro-7H-benzo[h]
benzothiazolo[2, 3-b]quinazoline (4e)
(4e) m.p. 215-217°C; yield: 80%, IR (KBr, cm
-1): 3045,
2977, 1650, 1610,1275
1H NMR (300 MHz, CDCl3)
δppm: 7.20-7.54 (m, 11H, Ar-H), 5.90 (s, 1H, C7-H),
3.76 (s, 3H, OCH3), 2.94-3.01 (m, 2H, CH2), 2.80-2.86
(m, 2H, CH2), 2.26 (s, 3H, CH3);
13CN M R( 7 5M H z ,
CDCl3) δppm: 18.26, 26.98, 28.68, 54.92, 57.23, 113.74,
114.96, 115.26, 123.64, 125.32, 125.76, 126.23, 126.64,
127.19, 127.84, 128.68, 128.96, 130.05, 132.92, 133.30,
134.52, 143.42, 156.39, 169.30; Anal. Calcd. for
C26H22N2OS: C, 76.07; H, 5.40; N, 6.82; Found: C,
76.01; H, 5.15; N, 6.92.
11-Methoxy-7-(4-methoxyphenyl)-5,6-dihydro-7H-benzo[h]
benzothiazolo-[2, 3-b]quinazoline (4f)
(4f) m.p. 227-229°C; yield: 80%, IR (KBr, cm
-1): 3100,
3080-3050, 1648, 1612;
1H NMR (300 MHz, CDCl3)
δppm: 7.15-7.52 (m, 11H, Ar-H), 5.90 (s, 1H, C7-H), δ
3.73 (s, 3H, OCH3), 3.69 (s, 3H, OCH3), 2.94-3.00 (m,
2H, CH2), 2.80-2.86 (m, 2H, CH2);
13CN M R( 7 5M H z ,
CDCl3) δppm: 28.26, 28.95, 54.20, 55.09, 56.96, 115.52,
117.52, 119.32, 120.44, 125.18, 126.48, 127.32, 127.47,
127.80, 128.12, 128.76, 133.07, 133.40, 134.23, 136.35,
137.98, 153.62, 158.26, 169.39; Anal. Calcd. for
C26H22N2O2S: C, 76.2; H, 5.2; N, 6.86; Found: C, 76.07;
H, 5.40; N, 6.82.
9,10-Dichloro-7-(4-methoxyphenyl)-5,6-dihydro-7H-benzo
[h]benzothiazolo[2, 3-b]quinazoline (4g)
(4g) m.p. 192-194°C; yield: 74%, IR (KBr, cm
-1): 3008-
3050, 2972, 1645, 1612, 1270;
1H NMR (300 MHz,
CDCl3) δppm: 7.12-7.54 (m, 10H, Ar-H), 5.92 (s, 1H,
C7-H), δ 3.73 (s, 3H,OCH3), 2.74-2.99 (m, 4H, CH2 at
C5 and C6);
13CN M R( 7 5M H z ,C D C l 3) δppm: 26.98,
28.12, 55.08, 58.74, 115.26, 115.35, 119.62, 120.43,
125.63, 127.48, 127.32, 127.58, 128.11, 128.45, 128.69,
130.24, 131.67, 133.40, 133.86, 134.26, 144.53, 155.62,
167.38; Anal. Calcd. for C25H18Cl2N2OS: C, 64.49; H,
3.88; N, 6.06; Found: C, 64.52; H, 3.90; N, 6.02.
11-Fluoro-7-(4-methoxyphenyl)-5,6-dihydro-7H-benzo[h]
benzothiazolo-[2, 3-b]quinazoline (4h)
(4h) m.p. 189-191°C; yield: 75%, IR(KBr, cm
-1): 3010-
3072, 2974, 1648, 1612, 1242;
1H NMR (300 MHz,
CDCl3) δppm: 7.12-7.54 (m, 11H, Ar-H), 5.95 (s, 1H,
C7-H), δ 3.69 (s, 3H, OCH3), 2.82-2.96 (m, 4H, CH2 at
C5 and C6);
13CN M R( 7 5M H z ,C D C l 3) δppm: 26.98,
28.56, 55.63, 57.39, 115.47, 118.78, 119.12, 121.45,
125.73, 126.63, 127.32, 127.58, 128.16, 128.73, 128.97,
131.43, 133.26, 133.89, 134.38, 142.19, 153.76, 170.43;
Anal. Calcd. for C25H19FN2O S :C ,7 2 . 4 0 ;H ,4 . 6 0 ;N ,
6.72; Found: C, 72.44; H, 4.62; N, 6.76.
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